Humana Inc. (NYSE:HUM) – Equities research analysts at Leerink Swann upped their Q3 2017 earnings per share estimates for Humana in a report released on Thursday. Leerink Swann analyst A. Gupte now expects that the insurance provider will post earnings of $3.24 per share for the quarter, up from their prior estimate of $3.18. Leerink Swann has a “Outperform” rating and a $265.00 price objective on the stock. Leerink Swann also issued estimates for Humana’s Q4 2017 earnings at $2.12 EPS, FY2017 earnings at $11.60 EPS, FY2019 earnings at $14.25 EPS and FY2020 earnings at $16.60 EPS.
Several other equities analysts also recently issued reports on HUM. UBS AG restated a “neutral” rating and set a $237.00 price objective (up previously from $205.00) on shares of Humana in a report on Wednesday, June 28th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $223.00 target price (up previously from $200.00) on shares of Humana in a research report on Thursday, August 3rd. Jefferies Group LLC reiterated a “hold” rating and issued a $257.00 target price on shares of Humana in a research report on Friday, August 4th. Zacks Investment Research lowered Humana from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Finally, BidaskClub lowered Humana from a “hold” rating to a “sell” rating in a research report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $243.00.
TRADEMARK VIOLATION WARNING: “Q3 2017 EPS Estimates for Humana Inc. (HUM) Raised by Analyst” was published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.com-unik.info/2017/08/19/q3-2017-eps-estimates-for-humana-inc-hum-raised-by-analyst-updated.html.
Shares of Humana (HUM) opened at 250.22 on Monday. The stock has a market capitalization of $36.16 billion, a P/E ratio of 20.58 and a beta of 0.91. Humana has a 12 month low of $163.50 and a 12 month high of $251.80. The company’s 50-day moving average is $237.33 and its 200 day moving average is $221.21.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The company had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same period last year, the business earned $2.30 EPS.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Chevy Chase Trust Holdings Inc. increased its position in Humana by 3.3% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 130,077 shares of the insurance provider’s stock valued at $26,814,000 after buying an additional 4,134 shares in the last quarter. Gulf International Bank UK Ltd increased its stake in shares of Humana by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 46,205 shares of the insurance provider’s stock worth $9,524,000 after buying an additional 620 shares during the period. National Pension Service increased its stake in shares of Humana by 2.2% in the first quarter. National Pension Service now owns 115,193 shares of the insurance provider’s stock worth $23,830,000 after buying an additional 2,499 shares during the period. Capstone Asset Management Co. increased its stake in shares of Humana by 2.0% in the first quarter. Capstone Asset Management Co. now owns 16,805 shares of the insurance provider’s stock worth $3,464,000 after buying an additional 334 shares during the period. Finally, Atria Investments LLC increased its stake in shares of Humana by 112.5% in the first quarter. Atria Investments LLC now owns 3,594 shares of the insurance provider’s stock worth $741,000 after buying an additional 1,903 shares during the period. 99.66% of the stock is owned by hedge funds and other institutional investors.
In related news, VP Heidi S. Margulis sold 1,500 shares of the stock in a transaction on Friday, May 26th. The stock was sold at an average price of $231.96, for a total value of $347,940.00. Following the completion of the transaction, the vice president now directly owns 8,150 shares of the company’s stock, valued at approximately $1,890,474. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Brian P. Leclaire sold 4,971 shares of the stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total value of $1,193,040.00. Following the completion of the transaction, the senior vice president now directly owns 14,258 shares of the company’s stock, valued at $3,421,920. The disclosure for this sale can be found here. 0.80% of the stock is currently owned by corporate insiders.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
What are top analysts saying about Humana Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Humana Inc. and related companies.